TG Therapeutics (NASDAQ:TGTX) Raised to Hold at StockNews.com
StockNews.com upgraded shares of TG Therapeutics (NASDAQ:TGTX – Free Report) from a sell rating to a hold rating in a research note issued to investors on Tuesday morning. TGTX has been the topic of a number of other reports. JPMorgan Chase & Co. upped their price objective on TG Therapeutics from $30.00 to $43.00 and […]
StockNews.com upgraded shares of TG Therapeutics (NASDAQ:TGTX – Free Report) from a sell rating to a hold rating in a research note issued to investors on Tuesday morning. TGTX has been the topic of a number of other reports. JPMorgan Chase & Co. upped their price objective on TG Therapeutics from $30.00 to $43.00 and […]
